CPT® Code 83901

Deleted

1. Indications

The molecular diagnostics test using target amplification is indicated for a variety of clinical scenarios, particularly when there is a need to identify specific genetic material associated with diseases. The following conditions may warrant the use of this procedure:

• Cancer Diagnosis Molecular diagnostics can help in identifying specific genetic mutations or alterations that are characteristic of certain types of cancer, aiding in diagnosis and treatment planning.
• Infectious Diseases The test is useful for detecting the presence of pathogens, such as viruses or bacteria, by amplifying their nucleic acid sequences, which can confirm infections.
• Hematological Disorders Conditions affecting blood cells, such as leukemias or lymphomas, can be evaluated through molecular diagnostics to identify genetic changes that may influence treatment options.
• Neurological Disorders Genetic testing can assist in diagnosing inherited neurological conditions by identifying specific gene mutations.
• Inherited Genetic Disorders The procedure is indicated for screening and diagnosing genetic disorders that are passed down through families, allowing for early intervention and management.

2. Procedure

The procedure for molecular diagnostics using target amplification involves several key steps, each critical to ensuring accurate results. The following outlines the procedural steps:

• Step 1: Sample Collection A biological sample, such as blood, urine, sputum, or tissue, is collected from the patient. This sample serves as the source of nucleic acids for the test.
• Step 2: Nucleic Acid Isolation The nucleic acid (DNA or RNA) is isolated from the collected sample. This step is crucial as it prepares the genetic material for amplification and is performed as a separate, reportable procedure.
• Step 3: Target Amplification The isolated nucleic acid undergoes target amplification, where specific sequences are replicated to generate multiple copies. This amplification is essential for detecting low-abundance targets in the sample.
• Step 4: Reporting Additional Sequences If the amplification involves more than two nucleic acid sequences, each additional sequence is reported separately using CPT® code 83901. The first two sequences are reported using CPT® code 83900.

3. Post-Procedure

After the molecular diagnostics procedure, the results are analyzed and interpreted by qualified laboratory personnel. The findings can provide critical information regarding the presence of specific genetic markers or pathogens. Depending on the results, further clinical action may be required, such as additional testing, treatment planning, or patient counseling. It is essential for healthcare providers to communicate the results effectively to patients and consider any necessary follow-up actions based on the diagnostic outcomes.